Clinical trial Recruiting at 1 site Interventional Ages 25 to 45

Cervicothoracic Mobilization for Supraspinatus Tendinitis

Official title: Effects of Cervicothoracic Mobilization on Shoulder Pain, Range of Motion, and Disability in Patients With Supraspinatus Tendinitis

Run by Riphah International University · NCT07921017 · Data updated 2026-11-12

A randomized trial tests whether adding cervicothoracic joint mobilization to standard physical therapy helps reduce shoulder pain and improve motion in adults with supraspinatus tendinitis.

Quick facts

Study typeInterventional
Ages25 Years to 45 Years
SexAll
Enrollment62 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 29, 2026
Main results expectedDecember 2, 2026
Study endsJanuary 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07921017 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–45 with a clinical diagnosis of supraspinatus tendinitis confirmed by Jobe’s test and related signs.

Probably not a fit

Individuals with prior shoulder surgery, non-supraspinatus shoulder pathology, osteoporosis, spinal fractures, tumors, or AC joint arthritis may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 62 adults with supraspinatus tendinitis, assigning 31 to receive cervicothoracic mobilization in addition to conventional physiotherapy and 31 to receive conventional physiotherapy alone. The experimental treatment uses Maitland’s Grade III-IV central PA and transverse oscillatory techniques targeting the cervicothoracic junction (C6-T4). Outcomes include pain with a numeric rating scale, shoulder range of motion, and disability via the SPADI, measured at baseline and after the intervention. Data will be analyzed with independent t-tests using SPSS to determine if the addition of cervicothoracic mobilization yields greater improvements than conventional therapy alone.

Why it matters

Potential benefit: If successful, patients may experience greater reductions in shoulder pain and better function through improved cervicothoracic mobility.

How similar studies have gone: Evidence for cervicothoracic mobilization in supraspinatus tendinitis is limited, making this trial relatively novel in this specific population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female patients both are included age ranging from 25 to 45 years.
* Diagnosis confirmed through Jobe's Test (Empty can) and characteristic signs and symptoms of supraspinatus tendinitis.

Exclusion Criteria:

* History of any previous surgical intervention involving the shoulder.
* Shoulder joint instability due to causes other than supraspinatus pathology.
* Presence of acromioclavicular joint arthritis.
* Participants were excluded if they had osteoporosis, spinal fractures, or tumors.

Where it's running

  • Itefaq Hospital and PMC by Dr. Waqar Ali
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.